1. Home
  2. Disease & Disorders
  3. New York, NY
  4. Crohns & Colitis Foundation

Crohns & Colitis Foundation

Crohns & Colitis Foundation has an America's Best Score of 51 out of 100, based on its 2025 Form 990, below the 60-point bar to be ranked.

  • New York, NY
  • Tax-exempt since 1966
  • EIN: 13-6193105
crohnscolitisfoundation.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
51OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Crohns & Colitis Foundation is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G70Z). Contributions are tax-deductible.

733 3Rd Ave Ste 510, New York, NY 10017-3218

Among the 85 scored disease & disorders organizations in New York, Crohns & Colitis Foundation holds 0.7 months of operating reserves (peer median 11.2 months), runs a typical yearly surplus of 0.4% (peers: surplus of 0.8%), and has grown spending 1.1% a year (peers: grown spending 6.1% a year).

In fiscal year 2025 it reported $87,451,370 in revenue and $85,269,824 in expenses, with contributions making up 84.7% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

For over five decades, the crohn's & colitis foundation ("the foundation") has been dedicated to its mission of finding a cure for crohn's disease and ulcerative colitis and improving the quality of life of children and adults affected by these diseases. (See sched o)the foundation has defined itself by sponsoring the best and brightest researchers resulting in groundbreaking studies and research initiatives to advance the understanding and treatment of inflammatory bowel diseases ("ibd").

Largest programs · fiscal year 2025

  • The crohn's & colitis foundation is a leading nonprofit funder of research focused on preventing, treating, and ultimately curing inflammatory bowel diseases (ibd), including crohn's disease and ulcerative colitis. Through strategic investments in basic, translational, clinical, and population-health research, the foundation supports investigators and institutions working to advance scientific und… Read more

    The crohn's & colitis foundation is a leading nonprofit funder of research focused on preventing, treating, and ultimately curing inflammatory bowel diseases (ibd), including crohn's disease and ulcerative colitis. Through strategic investments in basic, translational, clinical, and population-health research, the foundation supports investigators and institutions working to advance scientific understanding of disease causes, progression, treatment response, and long-term patient outcomes. During the year, the foundation funded research grants, collaborative networks, and innovation initiatives designed to accelerate the development of new therapies, precision medicine approaches, and improved standards of care for individuals living with ibd. (Cont. On schedule o)a cornerstone of the foundation's research strategy is ibd plexus, one of the world's most comprehensive research platforms for inflammatory bowel disease. Ibd plexus integrates clinical, genomic, biologic, and patient-reported data to facilitate discovery and enable researchers to identify new treatment targets, biomarkers, and personalized care approaches. The foundation also supports multidisciplinary collaborations, investigator training, commercial innovation partnerships, and specialty research initiatives addressing nutrition, surgery, pediatric disease, and other critical areas of unmet need. These efforts are intended to accelerate the translation of scientific discoveries into meaningful improvements in patient care and quality of life.

    $34,905,368 spent · 52.0% of program spending
  • The crohn's & colitis foundation provides education, support services, and advocacy programs designed to improve the lives of individuals living with inflammatory bowel diseases and their families. The foundation delivers evidence-based information through in-person and virtual educational programs, webinars, conferences, publications, digital resources, and its ibd help center. Virtual support gr… Read more

    The crohn's & colitis foundation provides education, support services, and advocacy programs designed to improve the lives of individuals living with inflammatory bowel diseases and their families. The foundation delivers evidence-based information through in-person and virtual educational programs, webinars, conferences, publications, digital resources, and its ibd help center. Virtual support groups, camp oasis, and myibd connections programs provide dedicated resources created for the specific needs of underrepresented communities. All of these programs help patients, caregivers, and healthcare professionals better understand disease management, treatment options, nutrition, emotional well-being, and long-term care strategies. (Cont. On schedule o)the foundation also works to improve access to quality care and advance patient-centered outcomes through professional education programs, quality-of-care initiatives, support communities, and public policy advocacy. During the year, the foundation convened healthcare professionals, researchers, patients, and caregivers through educational events, scientific publications, and community engagement activities that promote awareness, reduce stigma, and foster informed decision-making. Through these efforts, the foundation seeks to empower people affected by ibd, improve health outcomes, and ensure that the patient perspective remains central to research, treatment, and healthcare policy discussions.

    $32,164,792 spent · 48.0% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 79¢ went to programs, 13¢ to management and 8¢ to fundraising.

  • Programs $67,070,160
  • Management $11,337,609
  • Fundraising $6,862,055

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score51 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves0.7 mo; 2.0 mo in cash0.5 / 25
Financial balance (median margin)+0.4%12.6 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth+1.1% / yr8 / 15
Track record60 years10 / 10
Debt load89.2% of assets0 / 10
Total51.1 → 51
Spending on programs
Not scored; America's Best needs 65%+
79%Meets

Compared with New York peers

MeasureThis organizationPeer median
Operating reserves0.7 mo11.2 mo
Typical margin+0.4%+0.8%
Spending growth+1.1% / yr+6.1% / yr
Debt load89.2%7.4%

Peers: the 85 New York disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$87,451,370Fiscal year 20252022: $81,491,22320222023: $81,765,24820232024: $85,182,34820242025: $87,451,3702025
Expenses$85,269,824Fiscal year 20252022: $82,569,90020222023: $86,537,97920232024: $83,504,82320242025: $85,269,8242025
Total assets$47,669,031Fiscal year 20252022: $57,441,64520222023: $54,000,12420232024: $50,647,40620242025: $47,669,0312025
Total liabilities$42,501,504Fiscal year 20252022: $51,378,79520222023: $52,035,31420232024: $47,415,73720242025: $42,501,5042025
Fiscal year ending December 2025
Revenue$87,451,370
Expenses$85,269,824
Net income$2,181,546
Net assets$5,167,527

Notable sources of revenue

Percent of total revenue
Contributions$74,111,073
Program services$11,841,865
Investment income$283,447
Other (net)$1,214,985

Assets / debt

Total assets$47,669,031
Total liabilities$42,501,504
Net assets$5,167,527

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$85,182,348
Expenses$83,504,823
Net income$1,677,525
Net assets$3,231,669

Notable sources of revenue

Percent of total revenue
Contributions$73,888,862
Program services$9,112,274
Investment income$1,327,009
Other (net)$854,203

Assets / debt

Total assets$50,647,406
Total liabilities$47,415,737
Net assets$3,231,669

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$81,765,248
Expenses$86,537,979
Net income−$4,772,731
Net assets$1,964,810

Notable sources of revenue

Percent of total revenue
Contributions$68,707,768
Program services$11,417,426
Investment income$475,561
Other (net)$1,164,493

Assets / debt

Total assets$54,000,124
Total liabilities$52,035,314
Net assets$1,964,810

Compensation

Officers and key employees$3,106,969
Share of expenses3.6%
Fiscal year ending December 2022
Revenue$81,491,223
Expenses$82,569,900
Net income−$1,078,677
Net assets$6,062,850

Notable sources of revenue

Percent of total revenue
Contributions$73,149,330
Program services$7,296,231
Investment income$384,080
Other (net)$661,582

Assets / debt

Total assets$57,441,645
Total liabilities$51,378,795
Net assets$6,062,850

Compensation

Officers and key employees$2,983,632
Share of expenses3.6%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?